Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May;97(5):400-5.
doi: 10.1111/j.1349-7006.2006.00193.x.

Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease

Affiliations

Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease

Keiko Hattori et al. Cancer Sci. 2006 May.

Abstract

Germline mutations of the VHL gene are responsible for VHL. Approximately 70% of VHL families display small intragenic mutations detectable by sequencing, whereas partial- or whole-gene deletions have been described in the majority of the remaining families. For such large deletions, complex genetic techniques other than sequencing might have to be used. In this study, we describe an RQ-PCR assay with TaqMan fluorescent probes to detect germline VHL deletions. The RQ-PCR primer/probe sets were designed for the three VHL coding exons as well as for the 5' promoter and 3' untranslated regions. The RQ-PCR assay for 30 normal and 10 known VHL deletion control samples demonstrated high sensitivity and specificity. We then screened 29 individuals from 19 classical VHL families (16 type 1, 2 type 2A, and one type 2B) and one PHEO family, as well as four solitary suspected cases, none displaying any sequence changes, for VHL deletions by the RQ-PCR assay. We detected germline deletions in 17 (89%) classical families including 15 type 1, one type 2A, and one type 2B. We also identified two mutation carriers and two non-carriers in our family cohort. The one PHEO family and four solitary cases did not display any deletion patterns. These findings indicated that the TaqMan-based RQ-PCR assay is a simple and potent technique for the rapid, sensitive, and specific investigation of VHL genetic diagnoses that could be used profitably before more complex large-deletion detection techniques.

PubMed Disclaimer

Figures

Figure 1
Figure 1
VHL gene structure and the locations of the five primer/probe sets for RQ‐PCR assay.
Figure 2
Figure 2
VHL gene dosage values detected by RQ‐PCR assay for the five primer/probe sets in 30 normal controls, 10 VHL deletion controls, and 33 Japanese patients. DNA samples of 30 healthy controls and patients, each of whom retained two copies of the VHL gene, displayed gene dosage values of approximately 1.0 (∼0.8 to ∼1.2), whereas the samples from 10 deletion controls and patients who each had a single copy of VHL displayed values of approximately 0.5 (∼0.4 to ∼0.6).

Similar articles

Cited by

References

    1. Lonser RR, Glenn GM, Walther M et al. Von Hippel–Lindau disease. Lancet 2003; 361: 2059–67. - PubMed
    1. Maher ER. Von Hippel–Lindau disease. Curr Mol Med 2004; 4: 833–42. - PubMed
    1. Latif F, Tory K, Gnarra J et al. Identification of the von Hippel‐Lindau disease tumor suppressor gene. Science 1993; 260: 1317–20. - PubMed
    1. Zbar B, Kishida T, Chen F et al. Germline mutations in the Von Hippel–Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 1996; 8: 348–57. - PubMed
    1. Zbar B, Kaelin W, Maher E, Richard S. Third International Meeting on von Hippel–Lindau disease. Cancer Res 1999; 59: 2251–3. - PubMed

Publication types

MeSH terms